Xie Enmin, Cai Huimin, Ye Zixiang, Yang Min, Feng Lei, Zhu Chenggang, Li Jia, Dou Kefei
Cardiometabolic Medicine Center, Fuwai Hospital, National Clinical Research Center for Cardiovascular Diseases, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, 167A, Beilishi Road, Xicheng District, Beijing, 100037, China.
Department of Cardiology, Fuwai Hospital, National Clinical Research Center for Cardiovascular Diseases, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Cardiovasc Diabetol. 2025 Jul 2;24(1):262. doi: 10.1186/s12933-025-02807-4.
Prediabetes and insulin resistance are linked to the presence and progression of coronary artery calcification, but their prognostic significance in individuals with moderate-to-severe coronary artery calcification (MSCAC) remains unclear. The triglyceride-glucose (TyG) index, a validated surrogate marker of insulin resistance and a reliable predictor of cardiovascular outcomes, has not been thoroughly investigated for its role in risk stratification in patients with MSCAC. This study sought to evaluate the prognostic value of different prediabetes definitions and to determine whether the TyG index enhances risk stratification in this population.
This prospective cohort study consecutively enrolled 4195 patients with angiography-detected MSCAC. Prediabetes was defined using two criteria: the American Diabetes Association (ADA) criteria (fasting plasma glucose [FPG] 5.6-6.9 mmol/L and/or hemoglobin A1c [HbA1c] 5.7-6.4%), and the World Health Organization (WHO)/International Expert Committee (IEC) criteria (FPG 6.1-6.9 mmol/L and/or HbA1c 6.0-6.4%). The primary outcome was the incidence of major adverse cardiovascular events (MACE), including cardiovascular death, nonfatal myocardial infarction, and stroke.
The prevalence of ADA-defined prediabetes was 36.6%, nearly twice that of WHO/IEC-defined prediabetes (17.9%). Over a median follow-up of 3.1 years, WHO/IEC-defined prediabetes was significantly associated with an increased risk of MACE compared to normoglycemia (adjusted hazard ratio [HR] 1.79, 95% confidence interval [CI] 1.07-2.99), while ADA-defined prediabetes was not. Patients in the highest TyG index tertile had a significantly higher MACE risk than those in the lowest tertile (adjusted HR 2.25, 95% CI 1.30-3.90). Restricted cubic spline analysis demonstrated a positive linear association between the TyG index and MACE risk (P for nonlinearity > 0.05). Notably, individuals with both WHO/IEC-defined prediabetes and a high TyG index had an even higher MACE risk (adjusted HR 2.43, 95% CI 1.12-5.32), whereas those with prediabetes and a low TyG index did not demonstrate a comparable increase (adjusted HR 1.60, 95% CI 0.90-2.85). Incorporating both WHO/IEC-defined glycemic status and the TyG index into the baseline risk model significantly improved its predictive accuracy compared to including either marker alone, as indicated by enhancements in the C-statistic, continuous net reclassification improvement, and integrated discrimination improvement. These findings were consistent in subgroup analyses and sensitivity analyses.
This study highlights the prognostic value of WHO/IEC-defined prediabetes and the TyG index in identifying high-risk individuals among patients with MSCAC. Integrating these measures into clinical risk assessment may enhance prognostic accuracy and inform more targeted prevention strategies.
糖尿病前期和胰岛素抵抗与冠状动脉钙化的存在及进展相关,但其在中重度冠状动脉钙化(MSCAC)个体中的预后意义仍不明确。甘油三酯-葡萄糖(TyG)指数是一种经过验证的胰岛素抵抗替代指标和心血管结局的可靠预测因子,其在MSCAC患者风险分层中的作用尚未得到充分研究。本研究旨在评估不同糖尿病前期定义的预后价值,并确定TyG指数是否能增强该人群的风险分层。
这项前瞻性队列研究连续纳入了4195例经血管造影检测为MSCAC的患者。糖尿病前期采用两种标准定义:美国糖尿病协会(ADA)标准(空腹血糖[FPG]5.6 - 6.9 mmol/L和/或糖化血红蛋白[HbA1c]5.7 - 6.4%),以及世界卫生组织(WHO)/国际专家委员会(IEC)标准(FPG 6.1 - 6.9 mmol/L和/或HbA1c 6.0 - 6.4%)。主要结局是主要不良心血管事件(MACE)的发生率,包括心血管死亡、非致命性心肌梗死和中风。
ADA定义的糖尿病前期患病率为36.6%,几乎是WHO/IEC定义的糖尿病前期患病率(17.9%)的两倍。在中位随访3.1年期间,与血糖正常相比,WHO/IEC定义的糖尿病前期与MACE风险增加显著相关(调整后风险比[HR]1.79,95%置信区间[CI]1.07 - 2.99),而ADA定义的糖尿病前期则不然。TyG指数最高三分位数的患者MACE风险显著高于最低三分位数的患者(调整后HR 2.25,95%CI 1.30 - 3.90)。受限立方样条分析显示TyG指数与MACE风险之间存在正线性关联(非线性P>0.05)。值得注意的是,同时患有WHO/IEC定义的糖尿病前期和高TyG指数的个体MACE风险更高(调整后HR 2.43,95%CI 1.12 - 5.32),而患有糖尿病前期和低TyG指数者并未表现出类似的增加(调整后HR 1.60,95%CI 0.90 - 2.85)。与单独纳入任何一个指标相比,将WHO/IEC定义的血糖状态和TyG指数纳入基线风险模型显著提高了其预测准确性。C统计量、连续净重新分类改善和综合判别改善均表明了这一点。这些发现在亚组分析和敏感性分析中是一致的。
本研究强调了WHO/IEC定义的糖尿病前期和TyG指数在识别MSCAC患者中的高危个体方面的预后价值。将这些指标纳入临床风险评估可能会提高预后准确性,并为更具针对性的预防策略提供依据。